Life sciencesHumansAnimalsEpigenesisGeneticFatty Liver
METTLING in the pathogenesis of metabolic dysfunction-associated steatotic liver disease.
Ya-Qian Feng, Yuan-Hai Sun, Ling-Huan Li, Han-Bing Li
Published: 202510.1016/j.lfs.2025.124082
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) progresses through distinct stages from hepatic lipid deposition or steatosis to metabolic dysfunction-associated steatohepatitis (MASH), and ultimately to cirrhosis or hepatocellular c…
Preview only. Read the full abstract at the source